Skip to main content
| News

Basel Healthtech fund successfully closed

07.12.2021

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first funds to invest in innovative European Healthtech firms in the growth phase.

Christoph Kausch, Managing Partner and Co-Founder of MTIP (img: MTIP)

MTIP has completed the fundraising phase for its second fund. As the Basel-based private equity firm announced on December 7, it raised a total of 250 million US dollars in capital commitments under its MTIP Fund II instead of the original target of 225 million US dollars.

The “dark green”, sustainability-focused fund is one of the first of its kind to specialize in the Healthtech sector. It invests in digital health companies and digitally-connected medical technology firms with the aim of supporting international expansion plans. “We are excited to announce the successful closing of our second fund and continue our mission to build the Healthtech leaders of tomorrow”, explains Christoph Kausch, Managing Partner at MTIP, in the press release.

New and existing investors in the fund included institutional investors, pension funds, family offices, hospitals, foundations and the health insurance firm Sanitas, further details of which can be found in the press release. Andreas Schönenberger, CEO of Sanitas, praised MTIP’s “unique expertise in Healthtech” that allows it to foster innovation “in this under-served private equity sector”.

MTIP writes further in the press release that it has already made successful investments in five companies as part of its MTIP Fund II: OvivaTrialbeeKoa HealthIntelligencia and Mediktor.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area achieves milestone with settling of LifeMine
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Basel Area achieves milestone with settling of LifeMine

Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel...

Read More
Space Pharmaceuticals establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Space Pharmaceuticals establishes presence in Basel

Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company...

Read More
Basel Area Business & Innovation, Innovation, Life Sciences / biotech

NextImmune to benefit from Venture Kick financing

The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from...

Read More
Basel Area Business & Innovation, Innovation, Medtech, Switzerland Innovation Park

OECD impressed by the canton of Jura’s innovation system

The OECD has examined the innovation systems in place in rural areas of its member states, including the canton of...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest

ti&m opens branch in Basel

ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is...

Read More
What can artificial intelligence do for health?
Basel Area Business & Innovation, Digital Health, Innovation, Life Sciences / biotech, Medtech

What can artificial intelligence do for health?

Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been...

Read More
1 2 3 56

Do you have a question? We'd like to hear from you.